HC Wainwright & Co. Upgrades Inovio Pharmaceuticals to Buy, Announces $5 Price Target
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsUpgradesPrice Target
HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.
HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.